Bone morphogenetic protein (BMP) signaling regulates mitotic checkpoint protein levels in human breast cancer cells

Cellular Signalling

Volumn 24, Issue 4, 2012, Pages 961-968

  Yan, Hualong ^a,b   Zhu, Songcheng ^a   Song, Chenlin ^a   Liu, Naifa ^b   Kang, Jiuhong ^a  

^a TONGJI UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

Bone morphogenetic proteins (BMPs); Breast cancer; Mitotic checkpoint; Transforming Growth Factor (TGF )

Indexed keywords

ACTIVIN A; BONE MORPHOGENETIC PROTEIN; BUB3 PROTEIN; CELL PROTEIN; HEC1 PROTEIN; PROTEIN MAD2; SMAD1 PROTEIN; SMAD5 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TTK PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE CHECKPOINT; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ACTIVINS; BENZAMIDES; BONE MORPHOGENETIC PROTEINS; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DIOXOLES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; NOCODAZOLE; NUCLEAR PROTEINS; PLASMIDS; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PYRAZOLES; PYRIMIDINES; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84856225554     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2011.12.019     Document Type: Article

References (35)

1. Kops G.J., Weaver B.A., Cleveland D.W. Nature Reviews Cancer 2005, 5:773-785.
2. Foijer F., Draviam V.M., Sorger P.K. Biochimica et Biophysica Acta 2008, 1786:73-82.
3. Stegmeier F., Rape M., Draviam, et al. Nature 2007, 446:876-881.
4. Peters J.M. Nature Reviews Molecular Cell Biology 2006, 7:644-656.
5. Nowak M.A., Komarova N.L., Sengupta A., et al. Proceedings of the National Academy of Sciences United States of America 2002, 99:16226-16231.
6. Yoon D.S., Wersto R.P., Zhou W., et al. American Journal of Pathology 2002, 161:391-397.
7. Tighe A., Johnson V.L., Albertella M., Taylor S.S. EMBO Reports 2001, 2:609-614.
8. Yuan B., Xu Y., Woo J.H., et al. Clinical Cancer Research 2006, 12:405-410.
9. Martin-Lluesma S., Stucke V.M., Nigg E.A. Science 2002, 297:2267-2270.
10. Massaguéand J., Chen Y.G. Genes & Development 2000, 14:627-644.
11. Fang F., Turcan S., Rimner A., et al. Science Translational Medicine 2011, 3. 75ra25.
12. Bos P.D., Zhang X.H., Nadal C., et al. Nature 2009, 459:1005-1009.
13. Cheng K.H., Ponte J.F., Thiagalingam S. Cancer Research 2004, 64:1639-1646.
14. Lengauer C., Kinzler K.W., Vogelstein B. Nature 1997, 386:623-627.
15. Ye L., Bokobza S.M., Jiang W.G. International Journal of Molecular Medicine 2009, 24:591-597.
16. Alarmo E.L., Kuukasjärvi T., Karhu R., Kallioniemi A. Breast Cancer Research and Treatment 2007, 103:239-246.
17. Xu Q., Zhu S., Wang W., Zhang X., et al. Molecular Biology of the Cell 2009, 20:10-20.
18. Zhu S., Wang W., Clarke D.C., Liu X. Journal of Biological Chemistry 2007, 282:18327-18338.
19. Li M., Li S., Yuan J., Sun S.C. PLoS One 2009, 4:e7701.
20. Hao J., Daleo M.A., Murphy C.K., et al. PLoS One 2008, 3:e2904.
21. Inman G.J., Nicolas F.J., Callahan J.F., et al. Molecular Pharmacology 2002, 62:65-74.
22. Mollinedo F., Gajate C. Apoptosis 2003, 8:413-450.
23. Shapiro G.I. Journal of Clinical Oncology 2006, 24:1770-1783.
24. Tabuchi Y., Matsuoka J., Gunduz M., et al. International Journal of Oncology 2009, 34:313-319.
25. Draviam V.M., Xie S., Sorger P.K. Current Opinion Genetics & Development 2004, 14:120-125.
26. Weaver B.A., Silk A.D., Montagna C., et al. Cancer Cell 2005, 8:7-12.
27. Alarmo E.L., Kallioniemi A. Endocrine-Related Cancer 2010, 17:R123-R139.
28. Alarmo E.L., Parssinen J., Ketolainen J.M., et al. Cancer Letters 2009, 75:35-43.
29. Katsuno Y., Hanyu A., Kanda H., et al. Oncogene 2008, 27:6322.
30. Davies S.R., Watkins G., Douglas-Jones A., et al. Journal of Experimental Therapeutics and Oncology 2008, 7:327-338.
31. Ketolainen J.M., Alarmo E.L., Tuominen V.J., Kallioniemi A. Breast Cancer Research and Treatment 2010, 124:377-386.
32. Jallepalli P.V., Lengauer C. Nature Reviews. Cancer 2001, 1:109-117.
33. Hernando E., Nahlé Z., Juan G., et al. Nature 2004, 430:797-802.
34. Crosby M.E., Jacobberger J., Gupta D., et al. Oncogene 2007, 26:1897-1909.
35. Ferretti C., Totta P., Fiore M., et al. Cell Cycle 2010, 9:4174-4182.